Mesogastrium Metastasis in Colon Cancer
ConditionColon Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorJichao Qin
About this trial
Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.
Eligibility criteria
Qualifiers
Age between 18 and 75 years
American Society of Anesthesiologists (ASA) score I to III
A biopsy proven histological diagnosis of colorectal carcinoma
Preoperative staging cT2-4aN0M0 or cTanyN+M0
Disqualifiers
Synchronous colorectal carcinoma
Clinical evidence of metastasis
History of colorectal cancer or other malignant tumors
Preoperative staging cT1N0 or cT4bNany
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Jichao Qin
Lead sponsor
Tongji Hospital
Sponsor institution
Source ClinicalTrials.gov